Saturn V Capital Management as of June 30, 2023
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 20 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chinook Therapeutics | 11.2 | $20M | 525k | 38.42 | |
| Crinetics Pharmaceuticals In (CRNX) | 9.4 | $17M | 939k | 18.02 | |
| Cogent Biosciences (COGT) | 7.5 | $14M | 1.1M | 11.84 | |
| Cytokinetics Com New (CYTK) | 7.3 | $13M | 406k | 32.62 | |
| Cymabay Therapeutics | 7.2 | $13M | 1.2M | 10.95 | |
| Kalvista Pharmaceuticals (KALV) | 7.0 | $13M | 1.4M | 9.00 | |
| Biogen Idec (BIIB) | 6.5 | $12M | 41k | 284.85 | |
| Horizon Therapeutics Pub L SHS | 5.7 | $10M | 100k | 102.85 | |
| Apellis Pharmaceuticals (APLS) | 5.4 | $9.8M | 107k | 91.10 | |
| Morphic Hldg (MORF) | 4.8 | $8.7M | 152k | 57.33 | |
| Iteos Therapeutics | 4.7 | $8.4M | 636k | 13.24 | |
| BioMarin Pharmaceutical (BMRN) | 4.5 | $8.0M | 93k | 86.68 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.9 | $7.0M | 78k | 89.25 | |
| BioCryst Pharmaceuticals (BCRX) | 3.7 | $6.7M | 955k | 7.04 | |
| Sarepta Therapeutics (SRPT) | 3.4 | $6.2M | 54k | 114.52 | |
| Astria Therapeutics (ATXS) | 2.9 | $5.3M | 638k | 8.33 | |
| Syndax Pharmaceuticals (SNDX) | 2.0 | $3.6M | 174k | 20.93 | |
| Sage Therapeutics (SAGE) | 1.8 | $3.3M | 71k | 47.02 | |
| Argenx Se Sponsored Adr (ARGX) | 0.9 | $1.6M | 4.1k | 389.73 | |
| Scilex Holding | 0.0 | $58k | 10k | 5.57 |
